172 related articles for article (PubMed ID: 38661602)
1. Efficacy and Safety of Botulinum Toxin Type A for the Prevention of Postoperative Atrial Fibrillation.
Piccini JP; Ahlsson A; Dorian P; Gillinov AM; Kowey PR; Mack MJ; Milano CA; Noiseux N; Perrault LP; Ryan W; Steinberg JS; Voisine P; Waldron NH; Gleason KJ; Titanji W; Leaback RD; O'Sullivan A; Ferguson WG; Benussi S;
JACC Clin Electrophysiol; 2024 May; 10(5):930-940. PubMed ID: 38661602
[TBL] [Abstract][Full Text] [Related]
2. Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA Study.
Piccini JP; Ahlsson A; Dorian P; Gillinov MA; Kowey PR; Mack MJ; Milano CA; Perrault LP; Steinberg JS; Waldron NH; Adams LM; Bharucha DB; Brin MF; Ferguson WG; Benussi S
Am Heart J; 2022 Mar; 245():51-59. PubMed ID: 34687654
[TBL] [Abstract][Full Text] [Related]
3. Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery.
Waldron NH; Cooter M; Haney JC; Schroder JN; Gaca JG; Lin SS; Sigurdsson MI; Fudim M; Podgoreanu MV; Stafford-Smith M; Milano CA; Piccini JP; Mathew JP
Heart Rhythm; 2019 Feb; 16(2):178-184. PubMed ID: 30414840
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Suppression of Atrial Fibrillation by Botulinum Toxin Injection Into Epicardial Fat Pads in Patients Undergoing Cardiac Surgery: One-Year Follow-Up of a Randomized Pilot Study.
Pokushalov E; Kozlov B; Romanov A; Strelnikov A; Bayramova S; Sergeevichev D; Bogachev-Prokophiev A; Zheleznev S; Shipulin V; Lomivorotov VV; Karaskov A; Po SS; Steinberg JS
Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1334-41. PubMed ID: 26486855
[TBL] [Abstract][Full Text] [Related]
5. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: Three-year follow-up of a randomized study.
Romanov A; Pokushalov E; Ponomarev D; Bayramova S; Shabanov V; Losik D; Stenin I; Elesin D; Mikheenko I; Strelnikov A; Sergeevichev D; Kozlov B; Po SS; Steinberg JS
Heart Rhythm; 2019 Feb; 16(2):172-177. PubMed ID: 30414841
[TBL] [Abstract][Full Text] [Related]
6. The effect of intravenous N-acetylcysteine on prevention of atrial fibrillation after coronary artery bypass graft surgery: a double-blind, randomised, placebo-controlled trial.
Soleimani A; Habibi MR; Hasanzadeh Kiabi F; Alipour A; Habibi V; Azizi S; Emami Zeydi A; Sohrabi FB
Kardiol Pol; 2018; 76(1):99-106. PubMed ID: 28980294
[TBL] [Abstract][Full Text] [Related]
7. Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an updated meta-analysis.
Costanzo S; di Niro V; Di Castelnuovo A; Gianfagna F; Donati MB; de Gaetano G; Iacoviello L
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):906-11. PubMed ID: 23587470
[TBL] [Abstract][Full Text] [Related]
8. Epicardial placement of human placental membrane allografts in coronary artery bypass graft surgery is associated with reduced postoperative atrial fibrillation: a pilot study for a future multi-center randomized controlled trial.
Khalpey Z; Kumar U; Hitscherich P; Aslam U; Chnari E; Long M
J Cardiothorac Surg; 2024 Jun; 19(1):315. PubMed ID: 38824517
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: Rationale and design of the ALDOCURE trial.
Alexandre J; Ollitrault P; Fischer MO; Fellahi JL; Rozec B; Cholley B; Dolladille C; Chequel M; Allouche S; Legallois D; Saplacan V; Buklas D; Beygui F; Parienti JJ; Milliez P
Am Heart J; 2019 Aug; 214():88-96. PubMed ID: 31174055
[TBL] [Abstract][Full Text] [Related]
10. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study.
Gomes JA; Ip J; Santoni-Rugiu F; Mehta D; Ergin A; Lansman S; Pe E; Newhouse TT; Chao S
J Am Coll Cardiol; 1999 Aug; 34(2):334-9. PubMed ID: 10440141
[TBL] [Abstract][Full Text] [Related]
11. Predictors of post-operative atrial fibrillation in patients undergoing isolated coronary artery bypass grafting.
Gorczyca I; Michta K; Pietrzyk E; Wożakowska-Kapłon B
Kardiol Pol; 2018; 76(1):195-201. PubMed ID: 29168552
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic high-dose oral-N-acetylcysteine does not prevent atrial fibrillation after heart surgery: a prospective double blind placebo-controlled randomized clinical trial.
Kazemi B; Akbarzadeh F; Safaei N; Yaghoubi A; Shadvar K; Ghasemi K
Pacing Clin Electrophysiol; 2013 Oct; 36(10):1211-9. PubMed ID: 23731362
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative Magnesium Administration Does Not Reduce Postoperative Atrial Fibrillation After Cardiac Surgery.
Klinger RY; Thunberg CA; White WD; Fontes M; Waldron NH; Piccini JP; Hughes GC; Podgoreanu MV; Stafford-Smith M; Newman MF; Mathew JP
Anesth Analg; 2015 Oct; 121(4):861-867. PubMed ID: 26237622
[TBL] [Abstract][Full Text] [Related]
14. Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting Surgery.
Ferreira AF; A Saraiva F; Moreira R; J Cerqueira R; J Amorim M; Pinho P; P Lourenço A; F Leite-Moreira A
Rev Port Cir Cardiotorac Vasc; 2017; 24(3-4):129. PubMed ID: 29701361
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin Reduces the Incidence of Postoperative Atrial Fibrillation in Statin-Naive Patients Undergoing Isolated Heart Valve Surgery: A Double-Blind, Placebo-Controlled Randomized Trial.
Dehghani MR; Kasianzadeh M; Rezaei Y; Sepehrvand N
J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):465-72. PubMed ID: 25540059
[TBL] [Abstract][Full Text] [Related]
16. Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation.
Butt JH; Xian Y; Peterson ED; Olsen PS; Rørth R; Gundlund A; Olesen JB; Gislason GH; Torp-Pedersen C; Køber L; Fosbøl EL
JAMA Cardiol; 2018 May; 3(5):417-424. PubMed ID: 29590304
[TBL] [Abstract][Full Text] [Related]
17. Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study.
White CM; Sander S; Coleman CI; Gallagher R; Takata H; Humphrey C; Henyan N; Gillespie EL; Kluger J
J Am Coll Cardiol; 2007 Jan; 49(3):298-303. PubMed ID: 17239710
[TBL] [Abstract][Full Text] [Related]
18. N-3 polyunsaturated fatty acids for prevention of postoperative atrial fibrillation: updated meta-analysis and systematic review.
Wang H; Chen J; Zhao L
J Interv Card Electrophysiol; 2018 Mar; 51(2):105-115. PubMed ID: 29380237
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of botulinum toxin epicardial fat injection to prevent postoperative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials.
Abuelazm M; Saleh O; Kambalapalli S; Albarakat MM; Gowaily I; Mahmoud A; Abdelazeem B
Proc (Bayl Univ Med Cent); 2024; 37(2):279-286. PubMed ID: 38343481
[TBL] [Abstract][Full Text] [Related]
20. Association of Preoperative Renin-Angiotensin System Inhibitors With Prevention of Postoperative Atrial Fibrillation and Adverse Events: A Systematic Review and Meta-analysis.
Chen S; Acou WJ; Kiuchi MG; Meyer C; Sommer P; Martinek M; Schratter A; Andrea BR; Ling Z; Liu S; Yin Y; Hindricks G; Pürerfellner H; Krucoff MW; Schmidt B; Chun KRJ
JAMA Netw Open; 2019 May; 2(5):e194934. PubMed ID: 31150082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
